Clinical Trials Browser

INDUSTRY × tanespimycin × Dermatologic × Clear all

NCT00627419 2012-12-10

A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma

Phase 2 Terminated

Melanoma